Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height

Amgen

Amgen reported $543M in Interest Expense on Debt for its fiscal quarter ending in March of 2023.


Interest Expense On Debt Change
ALKERMES ALKS:US USD 5.29M 519K
Amgen AMGN:US USD 543M 128M
Biogen BIIB:US USD 62.5M 7.7M
BioMarin Pharmaceutical BMRN:US USD 3.7M 77K
Bristol-Myers Squibb BMY:US USD 288M 6M
Eli Lilly LLY:US USD 102.8M 18.8M
Genmab GEN:DC DKK 6M 1000K
Gilead Sciences GILD:US USD 230M 3M
Incyte Corp INCY:US USD 469K 198K
Intercept Pharmaceuticals ICPT:US USD 2.81M 3K
Ionis Pharmaceuticals IONS:US USD 1.61M 123K
J&J JNJ:US USD 215M 38M
Moderna Inc MRNA:US USD 9M 1000K
Neurocrine Biosciences NBIX:US USD 1.1M 0
Novartis NOVN:VX USD 211M 8M
Novartis NVS:US USD 211M 8M
Pfizer PFE:US USD 318M 5M
PTC Therapeutics PTCT:US USD 27.33M 1.43M
Puma Biotechnology PBYI:US USD 3.31M 33K
Regeneron Pharmaceuticals REGN:US USD 18M 600K
Roche Holding ROG:VX 348M 92M
Sarepta Therapeutics SRPT:US USD 6.32M 365K
Teva Pharmaceutical Industries Ltd TEVA:IT USD 260M 23M
Vertex Pharmaceuticals VRTX:US USD 11.4M 200K